KIR3DS1-mediated recognition of HLA-*B51: Modulation of KIR3DS1 responsiveness by self HLA-B allotypes and effect on NK cell licensing

Frontiers in Immunology

Volumn 8, Issue MAY, 2017, Pages

  Carlomagno, Simona ^a   Falco, Michela ^b   Bono, Maria ^b   Alicata, Claudia ^a   Garbarino, Lucia ^c   Mazzocco, Michela ^c   Moretta, Lorenzo ^d   Moretta, Alessandro ^a   Sivori, Simona ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b G GASLINI INSTITUTE   (Italy)

^c GALLIERA HOSPITAL   (Italy)

^d BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

Activating killer immunoglobulin like receptors; HLA B alleles; Human natural killer cells; KIR KIR L interaction; KIR3DS1; Natural killer cell education

Indexed keywords

HLA B51 ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DS1; NATURAL KILLER CELL RECEPTOR NKG2D;

ALLOTYPE; ANTIGEN RECOGNITION; ARTICLE; CELL CLONE; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS LINKING; CYTOFLUOROMETRY; FLOW CYTOMETRY; FLUORESCENCE ANALYSIS; GENE; GENE DOSAGE; GENETIC ANALYSIS; GENETIC TRANSFECTION; GENOTYPE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; KIR GENE; LYMPHOCYTE ACTIVATION; NATURAL KILLER CELL; PHENOTYPE; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; VIRUS INFECTION;

EID: 85019980972     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2017.00581     Document Type: Article

References (53)

1. Caligiuri MA. Human natural killer cells. Blood (2008) 112(3):461-9. doi:10.1182/blood-2007-09-077438
2. Vivier E, Raulet DH, Moretta A, Caligiuri MA, Zitvogel L, Lanier LL, et al. Innate or adaptive immunity? The example of natural killer cells. Science (2011) 331(6013):44-9. doi:10.1126/science.1198687
3. Parham P. MHC class I molecules and KIRs in human history, health and survival. Nat Rev Immunol (2005) 5(3):201-14. doi:10.1038/nri1570
4. Moretta A, Bottino C, Vitale M, Pende D, Biassoni R, Mingari MC, et al. Receptors for HLA class-I molecules in human natural killer cells. Annu Rev Immunol (1996) 14:619-48. doi:10.1146/annurev.immunol.14.1.619
5. Moretta A, Sivori S, Vitale M, Pende D, Morelli L, Augugliaro R, et al. Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells. J Exp Med (1995) 182(3):875-84. doi:10.1084/jem.182.3.875
6. Tomasello E, Olcese L, Vely F, Geourgeon C, Blery M, Moqrich A, et al. Gene structure, expression pattern, and biological activity of mouse killer cell activating receptor-associated protein (KARAP)/DAP-12. J Biol Chem (1998) 273(51):34115-9. doi:10.1074/jbc.273.51.34115
7. Parham P, Norman PJ, Abi-Rached L, Guethlein LA. Variable NK cell receptors exemplified by human KIR3DL1/S1. J Immunol (2011) 187(1):11-9. doi:10.4049/jimmunol.0902332
8. Korner C, Altfeld M. Role of KIR3DS1 in human diseases. Front Immunol (2012) 3:326. doi:10.3389/fimmu.2012.00326
9. Cella M, Longo A, Ferrara GB, Strominger JL, Colonna M. NK3-specific natural killer cells are selectively inhibited by Bw4-positive HLA alleles with isoleucine 80. J Exp Med (1994) 180(4):1235-42. doi:10.1084/jem.180.4.1235
10. 1. Blood (2008) 112(3):708-10. doi:10.1182/blood-2008-02-137521
11. Martin MP, Gao X, Lee JH, Nelson GW, Detels R, Goedert JJ, et al. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Genet (2002) 31(4):429-34. doi:10.1038/ng934
12. Alter G, Martin MP, Teigen N, Carr WH, Suscovich TJ, Schneidewind A, et al. Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes. J Exp Med (2007) 204(12):3027-36. doi:10.1084/jem.20070695
13. 1+ and KIR3DL1+ NK cells during acute human immunodeficiency virus type 1 infection. J Virol (2009) 83(13):6798-805. doi:10.1128/JVI.00256-09
14. Carr WH, Rosen DB, Arase H, Nixon DF, Michaelsson J, Lanier LL. Cutting edge: KIR3DS1, a gene implicated in resistance to progression to AIDS, encodes a DAP12-associated receptor expressed on NK cells that triggers NK cell activation. J Immunol (2007) 178(2):647-51. doi:10.4049/jimmunol.178.2.647
15. 57:01 by KIR3DS1. J Virol (2015) 89(10):5213-21. doi:10.1128/JVI.03586-14
16. 1. Nat Immunol (2016) 17(9):1067-74. doi:10.1038/ni.3513
17. Burian A, Wang KL, Finton KA, Lee N, Ishitani A, Strong RK, et al. HLA-F and MHC-I open conformers bind natural killer cell Ig-like receptor KIR3DS1. PLoS One (2016) 11(9):e0163297. doi:10.1371/journal.pone.0163297
18. 4I80 epitope and the killer cell immunoglobulin-like receptor 3DS1 gene against the development of hepatocellular carcinoma in patients with hepatitis C virus infection. J Infect Dis (2005) 192(1):162-5. doi:10.1086/430351
19. 1. Eur J Immunol (2016) 46(6):1511-7. doi:10.1002/eji.201546236
20. Jiang W, Johnson C, Jayaraman J, Simecek N, Noble J, Moffatt MF, et al. Copy number variation leads to considerable diversity for B but not A haplotypes of the human KIR genes encoding NK cell receptors. Genome Res (2012) 22(10):1845-54. doi:10.1101/gr.137976.112
21. Moretta A, Tambussi G, Bottino C, Tripodi G, Merli A, Ciccone E, et al. A novel surface antigen expressed by a subset of human CD3- CD16+ natural killer cells. Role in cell activation and regulation of cytolytic function. J Exp Med (1990) 171(3):695-714. doi:10.1084/jem.171.3.695
22. Moretta A, Vitale M, Sivori S, Bottino C, Morelli L, Augugliaro R, et al. Human natural killer cell receptors for HLA-class I molecules. Evidence that the Kp43 (CD94) molecule functions as receptor for HLA-B alleles. J Exp Med (1994) 180(2):545-55. doi:10.1084/jem.180.2.545
23. Pelak K, Need AC, Fellay J, Shianna KV, Feng S, Urban TJ, et al. Copy number variation of KIR genes influences HIV-1 control. PLoS Biol (2011) 9(11):e1001208. doi:10.1371/journal.pbio.1001208
24. Foley BA, De Santis D, Van Beelen E, Lathbury LJ, Christiansen FT, Witt CS. The reactivity of Bw4+ HLA-B and HLA-A alleles with KIR3DL1: implications for patient and donor suitability for haploidentical stem cell transplantations. Blood (2008) 112(2):435-43. doi:10.1182/blood-2008-01-132902
25. Saunders PM, Pymm P, Pietra G, Hughes VA, Hitchen C, O'Connor GM, et al. Killer cell immunoglobulin-like receptor 3DL1 polymorphism defines distinct hierarchies of HLA class I recognition. J Exp Med (2016) 213(5):791-807. doi:10.1084/jem.20152023
26. Fauriat C, Ivarsson MA, Ljunggren HG, Malmberg KJ, Michaelsson J. Education of human natural killer cells by activating killer cell immunoglobulin-like receptors. Blood (2010) 115(6):1166-74. doi:10.1182/blood-2009-09-245746
27. Pyo CW, Wang R, Vu Q, Cereb N, Yang SY, Duh FM, et al. Recombinant structures expand and contract inter and intragenic diversification at the KIR locus. BMC Genomics (2013) 14:89. doi:10.1186/1471-2164-14-89
28. Beziat V, Traherne JA, Liu LL, Jayaraman J, Enqvist M, Larsson S, et al. Influence of KIR gene copy number on natural killer cell education. Blood (2013) 121(23):4703-7. doi:10.1182/blood-2012-10-461442
29. Pando MJ, Gardiner CM, Gleimer M, McQueen KL, Parham P. The protein made from a common allele of KIR3DL1 (3DL1*004) is poorly expressed at cell surfaces due to substitution at positions 86 in Ig domain 0 and 182 in Ig domain 1. J Immunol (2003) 171(12):6640-9. doi:10.4049/jimmunol.171.12.6640
30. Carrington M, Alter G. Innate immune control of HIV. Cold Spring Harb Perspect Med (2012) 2(7):a007070. doi:10.1101/cshperspect.a007070
31. Vitale M, Sivori S, Pende D, Augugliaro R, Di Donato C, Amoroso A, et al. Physical and functional independency of p70 and p58 natural killer (NK) cell receptors for HLA class I: their role in the definition of different groups of alloreactive NK cell clones. Proc Natl Acad Sci U S A (1996) 93(4):1453-7. doi:10.1073/pnas.93.4.1453
32. 11): analysis of the functional relationship among different pathways of activation. Proc Natl Acad Sci U S A (1987) 84(6):1654-8. doi:10.1073/pnas.84.6.1654
33. Lee N, Geraghty DE. HLA-F surface expression on B cell and monocyte cell lines is partially independent from tapasin and completely independent from TAP. J Immunol (2003) 171(10):5264-71. doi:10.4049/jimmunol.171.10.5264
34. Ivarsson MA, Michaelsson J, Fauriat C. Activating killer cell Ig-like receptors in health and disease. Front Immunol (2014) 5:184. doi:10.3389/fimmu.2014.00184
35. Pende D, Marcenaro S, Falco M, Martini S, Bernardo ME, Montagna D, et al. Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity. Blood (2009) 113(13):3119-29. doi:10.1182/blood-2008-06-164103
36. Venstrom JM, Gooley TA, Spellman S, Pring J, Malkki M, Dupont B, et al. Donor activating KIR3DS1 is associated with decreased acute GVHD in unrelated allogeneic hematopoietic stem cell transplantation. Blood (2010) 115(15):3162-5. doi:10.1182/blood-2009-08-236943
37. Verheyden S, Schots R, Duquet W, Demanet C. A defined donor activating natural killer cell receptor genotype protects against leukemic relapse after related HLA-identical hematopoietic stem cell transplantation. Leukemia (2005) 19(8):1446-51. doi:10.1038/sj.leu.2403839
38. Mancusi A, Ruggeri L, Urbani E, Pierini A, Massei MS, Carotti A, et al. Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces nonrelapse mortality. Blood (2015) 125(20):3173-82. doi:10.1182/blood-2014-09-599993
39. 4 predicts for progression-free survival after autologous stem cell transplantation in patients with multiple myeloma. Blood (2010) 116(12):2033-9. doi:10.1182/blood-2010-03-273706
40. 1-activating receptor efficiently kill T-cell blasts and dendritic cells: implications in haploidentical HSCT. Blood (2011) 117(16):4284-92. doi:10.1182/blood-2010-10-316125
41. 2D receptor are released during HIV-1 infection and impair NKG2D expression and cytotoxicity of NK cells. FASEB J (2013) 27(6):2440-50. doi:10.1096/fj.12-223057
42. Guo H, Kumar P, Moran TM, Garcia-Sastre A, Zhou Y, Malarkannan S. The functional impairment of natural killer cells during influenza virus infection. Immunol Cell Biol (2009) 87(8):579-89. doi:10.1038/icb.2009.60
43. 5A-mediated imbalance of inflammatory cytokines. PLoS Pathog (2010) 6(11):e1001184. doi:10.1371/journal.ppat.1001184
44. Li Y, Wang JJ, Gao S, Liu Q, Bai J, Zhao XQ, et al. Decreased peripheral natural killer cells activity in the immune activated stage of chronic hepatitis B. PLoS One (2014) 9(2):e86927. doi:10.1371/journal.pone.0086927
45. Cerboni C, Neri F, Casartelli N, Zingoni A, Cosman D, Rossi P, et al. Human immunodeficiency virus 1 Nef protein downmodulates the ligands of the activating receptor NKG2D and inhibits natural killer cell-mediated cytotoxicity. J Gen Virol (2007) 88(Pt 1):242-50. doi:10.1099/vir.0.82125-0
46. 2D immunoreceptor and its ligands. Nat Rev Immunol (2003) 3(10):781-90. doi:10.1038/nri1199
47. 4+ T cell blasts by rIL-2 activated autologous natural killer cells from HIV-infected viremic individuals. PLoS Pathog (2008) 4(7):e1000101. doi:10.1371/journal.ppat.1000101
48. Pradeu T, Jaeger S, Vivier E. The speed of change: towards a discontinuity theory of immunity? Nat Rev Immunol (2013) 13(10):764-9. doi:10.1038/nri3521
49. Pinheiro da Silva F, Aloulou M, Benhamou M, Monteiro RC. Inhibitory ITAMs: a matter of life and death. Trends Immunol (2008) 29(8):366-73. doi:10.1016/j.it.2008.05.001
50. Ivashkiv LB. Cross-regulation of signaling by ITAM-associated receptors. Nat Immunol (2009) 10(4):340-7. doi:10.1038/ni.1706
51. Turnbull IR, Colonna M. Activating and inhibitory functions of DAP12. Nat Rev Immunol (2007) 7(2):155-61. doi:10.1038/nri2014
52. Stern M, Hadaya K, Honger G, Martin PY, Steiger J, Hess C, et al. Telomeric rather than centromeric activating KIR genes protect from cytomegalovirus infection after kidney transplantation. Am J Transplant (2011) 11(6):1302-7. doi:10.1111/j.1600-6143.2011.03516.x
53. Venstrom JM, Pittari G, Gooley TA, Chewning JH, Spellman S, Haagenson M, et al. HLA-C-dependent prevention of leukemia relapse by donor activating KIR2DS1. N Engl J Med (2012) 367(9):805-16. doi:10.1056/NEJMoa1200503